Efficacy and safety of Huxin formula in patients after CABG: a multicenter, double-blind, randomized clinical trial.
CONCLUSION: Huxin Formula may improve cardiac function of patients with 3 coronary vessel lesions and relieve symptoms of patients with cardiac function class II but failed to show superiority in primary outcomes.
PMID: 25592946 [PubMed - in process]
Source: Forschende Komplementarmedizin - Category: Complementary Medicine Tags: Forsch Komplementmed Source Type: research
More News: Cardiology | Clinical Trials | Complementary Medicine | Coronary Artery Bypass Graft | Coronary Heart Disease | Heart | Heart Attack | Heart Disease | Study